SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
158 hedge funds and large institutions have $742M invested in SANGAMO THERAPEUTICS INC in 2014 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 47 reducing their positions, and 21 closing their positions.
2,215% more call options, than puts
Call options by funds: $196M | Put options by funds: $8.47M
42% more capital invested
Capital invested by funds: $522M → $742M (+$221M)
29% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 21
9% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 47
1% more funds holding
Funds holding: 157 → 158 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$14.6M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.81M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$6.63M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$4.8M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$3.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.6M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.87M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$3.85M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$3.53M |
| 5 |
PCA
Private Capital Advisors
Darien,
Connecticut
|
-$3.21M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
176
Tower Research Capital (TRC)
New York
| – | -$5K | -425 | Closed |
|
177
Ameriprise
Minneapolis,
Minnesota
| – | -$5K | -420 | Closed |
|
|
OCM
178
One Capital Management
Westlake Village,
California
| – | -$1K | -100 | Closed |
|
|
BRWA
179
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | +$134 | +11 | New |
|
SGMO Hedge Fund Activity: Q4 2014 in Review
158 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2014, worth a combined $742M — up 42% from $522M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new SGMO positions and 21 closed out — a net gain of 6 holders — while 51 added to existing stakes and 47 trimmed.
The largest buyer was Bank of New York Mellon, adding an estimated $14.6M. The largest seller was Fidelity Investments, cutting an estimated $24.6M.
- 158 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2014, up from 157 in Q3 2014.
- Funds reported $742M of SANGAMO THERAPEUTICS INC stock for Q4 2014, up 42% quarter-over-quarter.
- 27 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2014 and 21 closed out, a net change of +6 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q4 2014 was Bank of New York Mellon, an estimated $14.6M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q4 2014 was Fidelity Investments, an estimated $24.6M sold.
Based on aggregated 13F filings for Q4 2014.